The tool is the first electronic clinical outcome assessment product of its kind to fully integrate with RTSM
Wayne, PA – Bracket, a leading clinical trial technology and specialty services provider, will launch its next generation clinical outcomes platform, Bracket eCOASM 6.0, at the 52nd Annual DIA Meeting held on June 26 – 30 in Philadelphia, Pennsylvania. A demonstration of eCOA 6.0, the first electronic clinical outcome assessment product of its kind to fully integrate with RTSM, will be held at DIA Booth #715.
Bracket eCOA 6.0 is a flexible platform for electronic clinical outcomes assessments that is driving digitization in clinical trials. The platform integrates with industry-leading Samsung Galaxy smartphones and
Microsoft’s Surface Pro Windows tablets to support ePro, eClinRO, and eObsRO, and features fully integrated clinician and patient-facing tools, to ensure the experience is fully harmonized for any user.
“Bracket eCOA combines science and technology to collect patient information through smartphones or tablets, and ultimately achieve higher quality outcomes and efficiency in clinical trials,” said Jeff Kinell, CEO for Bracket. “We are pleased to launch eCOA 6.0 and continue demonstrating our commitment to paper-free clinical trials as we prepare for the mobile revolution.”
The platform’s integration with industry leading Clinical IRT solution, Bracket RTSM, enables subject questionnaires that trigger enrollment eligibility and randomization to kickoff schedule of reported outcomes entries. Its advisory services support scale design, development, licensing and validation, rater training and certification, clinical review and quality assurance, data analytics, and compliance tracking.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.